Every second counts when someone is having a stroke and immediate care can mean the difference between life and death. While there is widespread consensus on the importance of identification and immediate care for acute stroke patients, a gap remains in the critical role of post-stroke care and secondary stroke prevention strategies. These critical matters impact the care of the more than 795,000 people in the United States who experience a stroke every year.

Merge empowers healthcare organizations with advanced medical imaging solutions to deliver reliable imaging, less complexity, and better care. 

June 27, 2025 – Foldax Inc., a leader in the development of innovative polymer heart valves, has announced compelling one-year results from the India Clinical Trial of the TRIA Mitral Valve, showing a good safety profile, sustained hemodynamic performance, and statistically significant improvement in patient quality of life. These are the first one-year outcomes ever presented for a multicenter clinical study of a polymer heart valve worldwide.

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at the American Diabetes Association’s 85th Scientific Sessions (ADA 2025). The analyses reveal that cardiac arrhythmias are common and often occur early in people with type 2 diabetes (T2D) — especially those who also have chronic kidney disease (CKD).

June 25, 2025 — Royal Philips and Methodist Hospitals recently announced the healthcare provider’s strategic investment in Philips’ advanced portfolio of image-guided therapy (IGT) solutions that integrate imaging systems and software, with specialized diagnostic and therapeutic devices. The new interventional suites will support critical health needs within the community including complex cardiovascular intervention, active stroke treatment, oncology therapies and care for other prevalent health conditions.

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging solutions will be on display at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana.


Despite advancements in ventricular arrhythmia (VA) screening, numerous high-profile athlete cases have highlighted the need for improved detection and management. A new study presented at Heart Rhythm 2025 in April evaluated the connection between complex VA patterns in athletes and underlying structural heart disease, offering critical insights into the prognostic value of both non-invasive and invasive assessments in athletes with complex VAs.



SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work from anywhere at any time.

Available from Core Sound Imaging, Studycast provides an intuitive workflow from viewing images to creating reports to archiving exams. Its cloud-based system puts a comprehensive imaging workflow at your fingertips from any browser.


June 16, 2025 – Penumbra, Inc. recently announced the completion of enrollment in the STORM-PE clinical trial. This prospective, multi-center randomized controlled trial enrolled 100 patients to evaluate computer assisted vacuum thrombectomy (CAVT) using Penumbra’s Lightning Flash plus anticoagulation, versus anticoagulation alone, for the treatment of acute intermediate-high risk pulmonary embolism (PE).

June 13, 2025 — An international study has shown that targeted online education on atrial fibrillation (AF) for health professionals can improve guideline-adherent care. 

Subscribe Now